Affymetrix Announces Webcast of Investor Day 2014 on Monday November 17, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--

Affymetrix, Inc. AFFX today announced that the company will host a live webcast in conjunction with its Investor Day on Monday, November 17, 2014 at 11:30 a.m. ET. Presentations from management will include a strategic update from Frank Witney, President & CEO, as well as a financial update from Gavin Wood, EVP & CFO.

There will also be presentations from leading researchers and customers including;

• The Importance of Biobanks - Dr. Peter Donnelly, Oxford University & Wellcome Trust Center for Human Genetics
• Translational Medicine Applications for RNA-ISH - Dr. David Ting, Massachusetts General Hospital Cancer Center, Harvard Medical School
• Advances in Non-Invasive Prenatal Testing - Dr. Ken Song, Chief Executive Officer, Ariosa Diagnostics
• Genetics & Cancer - Dr. Joshua Schiffman, Huntsman Cancer Institute, University of Utah

The live audio webcast and subsequent replay may be accessed by visiting the Investor Relations section of the company's website at
www.affymetrix.com. The archived webcast will be available shortly after conclusion of the presentation and will be available on the company's website for 14 days following the presentation.

About Affymetrix

Affymetrix technologies enable multiplex and simultaneous analysis of biological systems at the cell, protein, and gene level, facilitating the rapid translation of bench-top research into clinical and routine use for human health and wellness.

We strive to provide leadership and support, partnering with our customers in pharmaceutical, diagnostic, and biotechnology companies, as well as leading academic, government, and non-profit research institutes in their quest for answers toward using biology for a better world.

More than 2,300 microarray systems have been shipped around the world and more than 48,000 peer-reviewed papers have been published citing our technologies. Affymetrix is headquartered in Santa Clara, California, and has manufacturing facilities in Cleveland, Ohio, San Diego, Vienna and Singapore. The Company has about 1,100 employees worldwide and maintains sales and distribution operations across Europe, Asia, and Latin America. For more information about Affymetrix, please visit www.affymetrix.com.